Skip to main content

Advertisement

Log in

Genetic variation in apolipoprotein D and Alzheimer’s disease

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract.

Apolipoprotein D (apoD) is a lipoprotein–associated glycoprotein, structurally unrelated to apoE, that transports small hydrophobic ligands including cholesterol and sterols. Levels are increased in the hippocampus and CSF of Alzheimer’s disease (AD) patients. We tested whether variation in the APOD gene affects AD risk. Four single nucleotide polymorphisms (SNPs) were investigated (in map order): exon 2, 15T→C encodes an amino acid substitution Phe→Ser at codon 15; intron 2, –352G→A; intron 3, +45C→T; intron 4, +718C→T, determined by SNaPshot assay. SNP frequencies for 394 eastern Finnish AD patients were compared with those found for 470 control subjects, dividing subjects also into early–onset AD (EOAD; ≤ 65 years) and late–onset AD (LOAD; >65 years) groups. The –352G allele was associated with a significant 3–fold increase in the risk of EOAD (OR: 2.7; 95% CI: 1.1–6.5). The –352G containing haplotypes were more common for EOAD cases (TGCC: 0.48 vs 0.41; TGCT: 0.08 vs 0.01 (p = 0.002). In the Grade–of–membership analysis, APOD genotype frequencies at each SNP site and disease status were used to construct two latent groups: the affected group carried –352 as GG or GA and +45 CC, was often women and enriched in APOE ε4. Each method suggested that the –352G allele frequency is higher for EOAD in the eastern Finnish population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Belloir B, Kövari E, Surini-Demiri M, Savioz A (2001) Altered apolipoprotein D expression in the brain of patients with Alzheimer disease. J Neurosci Res 64:61–69

    Google Scholar 

  2. Boldt A, Petzl-Erler M (2002) A new strategy for mannose-binding lectin gene haplotyping. Hum Mutat 19:296–306

    Article  PubMed  Google Scholar 

  3. Connor JR, Milward EA, Moalem S, Sampietro M, Boyer P, Percy ME, Vergani C, Scott RJ, Chorney M (2001) Is hemochromatosis a risk factor for Alzheimer’s disease? J Alzheimer’s Dis 3:471–477

    CAS  Google Scholar 

  4. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261:921–923

    CAS  PubMed  Google Scholar 

  5. Desai PP, Bunker CH, Ukoli FAM, Kamboh MI (2002) Genetic variation in the apolipoprotein D gene among African blacks and its significance in lipid metabolism. Atherosclerosis 163:329–338

    Article  CAS  PubMed  Google Scholar 

  6. Desai PP, Hendrie HC, Evans RM, Murrell JR, DeKosky ST, Kamboh MI (2003) Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans. Am J Med Genet 116:98–101

    Google Scholar 

  7. Drayna DT, McLean JW, Wion KL, Trent JM, Drabkin HA, Lawn RM (1987) Human apolipoprotein D gene: gene sequence, chromosomal localization, and homology to the α-globulin superfamily. DNA 6:199–204

    CAS  PubMed  Google Scholar 

  8. Excoffier L, Slatkin M (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921–927

    CAS  PubMed  Google Scholar 

  9. Flower DR (1994) The lipocalin protein family: a role in cell regulation. FEBS Lett 354:7–11

    Article  CAS  PubMed  Google Scholar 

  10. Hiltunen M, Mannermaa A, Thompson D, Easton D, Pirskanen M, Helisalmi S, Koivisto AM, Lehtovirta M, Ryynänen M, Soininen H (2001) Genome-wide linkage disequilibrium mapping of late-onset Alzheimer’s disease in Finland. Neurology 57:1663–1668

    CAS  PubMed  Google Scholar 

  11. Kuusisto J, Koivisto K, Kervinen K, Mykkänen L, Helkala E-L,Vanhanen M, Hänninen T, Pyörälä K, Kesäniemi A, Riekkinen P, Laakso M (1994) Association of apolipoprotein E phenotype with late-onset Alzheimer’s disease: a population-based study. BMJ 309:636–638

    CAS  PubMed  Google Scholar 

  12. Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala E-L, Hartikainen P, Hänninen T, Ryynänen M, Riekkinen P Sr (1996) Clinical and neuropsychological characteristics in familial and sporadic Alzheimer’s disease: relation to apolipoprotein E polymorphism. Neurology 46:413–419

    CAS  PubMed  Google Scholar 

  13. Manton KG, Woodbury MA, Tolley HD (1994) Statistical Applications Using Fuzzy Sets. John Wiley & Sons, New York

  14. McKhann G, Drachman D, Folstein M, Katzman R, Prica D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944

    CAS  PubMed  Google Scholar 

  15. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, CERAD neuropathologists (1991) The Consortium to Establish a Registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486

    CAS  PubMed  Google Scholar 

  16. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM (1999) Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 53:1937–1942

    CAS  PubMed  Google Scholar 

  17. Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, Milne R (2000) Apolipoprotein D Biochim Biophys Acta 1482:185–198

    CAS  PubMed  Google Scholar 

  18. Raymond ML, Rousset F (1995) An exact test for population differentiation. Evolution 49:1280–1283

    Google Scholar 

  19. Richardson DR, Ponka P (1997) The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1331:1–40

    CAS  Google Scholar 

  20. Suresh S, Yan Z, Patel RC, Patel YC, Patel SC (1998) Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein DJ Neurochem 70:242–251

    CAS  PubMed  Google Scholar 

  21. Terrisse L, Poirier J, Bertrand P, Merched A, Visvikis S, Siest G, Milne R, Rassart E (1998) Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer’s patients. J Neurochem 71:1643–1650

    CAS  PubMed  Google Scholar 

  22. Thomas EA, Dean B, Pavey G, Sutcliffe JG (2001) Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc Natl Acad Sci USA 98:4066–4071

    Article  CAS  PubMed  Google Scholar 

  23. Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, Hashimoto Y, Kurokawa K, Teramoto T (1993) Determination by PCR-RFLP of apoE genotype in a Japanese population. J Lab Clin Med 121:598–602

    PubMed  Google Scholar 

  24. Vandenplas S, Grobler-Rabie A, Brebner K, Rickets M, Wallis G, Bester A, Boyd C, Mathew C (1984) Blot hybridisation of genomic DNA. J Med Genet 21:164–172

    CAS  PubMed  Google Scholar 

  25. Vijayaraghavan S, Hitman GA, Kopelman PG (1994) Apolipoprotein-D polymorphism – a genetic marker for obesity and hyperinsulinemia. J Clin Endocrinol Metab 79:568–570

    PubMed  Google Scholar 

  26. Ward RJ, Zhang Y, Crichton RR (2001) Aluminium toxicity and iron homeostasis. J Inorg Biochem 87:9–14

    Article  CAS  PubMed  Google Scholar 

  27. Woodbury MA, Clive J, Garson A Jr (1978) Mathematical typology: a grade of membership technique for obtaining disease definition. Comput Biomed Res 11:277–298

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Helisalmi PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Helisalmi, S., Hiltunen, M., Vepsäläinen, S. et al. Genetic variation in apolipoprotein D and Alzheimer’s disease. J Neurol 251, 951– 957 (2004). https://doi.org/10.1007/s00415-004-0470-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-004-0470-8

Key words

Navigation